The Sonion Group is owned by Novo Holdings A/S.

Novo Holdings A/S is the holding company within the Novo Group and is responsible for the management of the assets of the Novo Nordisk Foundation. The foundation is valued at more than 40 billion USD.  Novo Holdings A/S is a private limited liability company fully owned by the Novo Nordisk Foundation.

Novo Holdings A/S is the major shareholder in Novo Nordisk A/S and Novozymes A/S, and they provide seed and venture capital to development stage companies. As a result, they take significant ownership positions in well-established companies, within the life science and biotechnology community, as well as manage a broad portfolio of financial assets.

Christian Nielsen
CFO & Executive Vice President
Email: CN@sonion.com
Direct: +45 4630 6662